Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: A randomized, placebo-controlled, double-blind trial

OBJECTIVE: Evaluate the effects of ultra-low-dose hormone therapy (Ultra-LD HT) with 17β-estradiol 0.5 mg and norethisterone acetate 0.1 mg (E2 0.5/NETA 0.1) versus placebo on bone turnover markers (BTM) in postmenopausal women. STUDY DESIGN: A multicenter, double-blind, randomized, placebo-controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa-Paiva, Lucia, O Wender, Maria Celeste, Machado, Rogerio B, Pompei, Luciano M, Nahas, Eliana A, Nahas-Neto, Jorge, Del Debbio, Sonia Y, Badalotti, Mariangela, Cruz, Achilles M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500172/
https://www.ncbi.nlm.nih.gov/pubmed/35938207
http://dx.doi.org/10.1177/20533691221116769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500172/
https://www.ncbi.nlm.nih.gov/pubmed/35938207
http://dx.doi.org/10.1177/20533691221116769

Ejemplares similares